Humira is now officially approved by Health Canada to treat Crohn's disease

Humira is now officially approved by Health Canada to treat Crohn's disease.

Humira (adalimumab) is a biologic therapy...similar to Remicade (infliximab). Both drugs block tumor necrosis factor alpha (TNF-alpha)...to help reduce inflammation.

Humira is already used for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote